Calculator in the works to assess risk of major bleed from long-term aspirin use

New Zealand researchers are working on a new clinical decision-making tool that will be able to help clinicians weigh up the benefits and harms of long-term aspirin use for the prevention of cardiovascular disease on individual patients.

Researchers from the University of Auckland’s Faculty of Medical and Health Sciences and Middlemore Hospital have developed bleeding risk models for men and women that are able to provide a personalised estimate of a patient’s risk of a major bleed.

Posted in New Zealand eHealth

Tags: University of Auckland

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2019 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.